Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Name: Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
License: Public Domain

AbbVie

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

methicillin-resistant staphylococcus aureus, bacterial infections, staphylococcal skin infections

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174928
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.